Sep-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
In September 2026, Purefarma concentrated 76.99% of sales in Oil while Vapor Pens accounted for 23.00%, a split that widened month over month as Oil grew 14.61% MoM and Vapor Pens fell 21.94% MoM. Year over year, Oil rose 4.71% while Vapor Pens advanced 14.11%, and the brand’s average price declined 1.89% YoY to $27.79, with Oil priced at $28.42 and Vapor Pens at $25.86. With Oil ranked 7 in British Columbia and the brand’s overall sales up 6.73% YoY against a 31.23% decline over 24 months, the pattern implies short-term stabilization driven by Oil momentum while Vapor Pens volatility caps near-term mix diversification.
The sharper MoM pullback in Vapor Pens alongside a double-digit MoM lift in Oil suggests operational and demand dependencies are tilting further toward the Oil line, even as Vapor Pens posts a higher YoY rate at 14.11% versus Oil at 4.71%. Given a 76.99% Oil share and a 7th-place provincial rank in British Columbia, the mix implies Purefarma’s positioning leans into a defensible niche where modest pricing contraction (-1.89% YoY) supports volume, but category concentration raises risk if Oil growth cools; the actionable read is to use Oil-led visibility to selectively rebuild Vapor Pens MoM continuity without eroding the core.
Competitive Landscape
Purefarma sits at rank #7 in BC Oil in September 2026, unchanged YoY from rank #7, while improving 2 positions from #9 three months prior; this stability contrasts with NightNight climbing from #5 to #3 alongside a 25.97% YoY sales increase and Frank slipping from #4 to #5 with a -19.70% YoY decline. The category leader Glacial Gold held #1 YoY to #1 current despite a -15.35% YoY sales change, while MediPharm Labs advanced from #6 to #4 with 41.72% YoY growth; against that mix of upward mobility and contraction, Purefarma’s flat YoY rank but 2-position lift since June 2026 implies incremental share recovery is occurring, yet not at a pace that shifts its long-run competitive standing without further acceleration.

Notable Products
CBD 100 Hemplixir Oil (30ml) posted the steepest decline at -17.2% month over month and slid to rank 3 from a higher prior standing, while CBD Earth Full Spectrum Cartridge (1g) fell -21.9% and held rank 2, indicating the drag is concentrated in non-leading SKUs. In contrast, CBD Hemplixir 30 Oil (30ml) rose +27.4% and secured rank 1 with $26,962 in September 2026, and two of the top three SKUs are Oils, pointing to a category concentration that offsets weakness in Vapor Pens. The pattern implies Purefarma is consolidating around Oil-based CBD formats as the core revenue engine while tolerating volatility in the single Vape SKU.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.







